(Q41871086)

13 October 2017

Effect of zinc supplementation on oxidative drug metabolism in patients with hepatic cirrhosis (English)

1 reference

13 October 2017

Barry MG

1

1 reference

13 October 2017

Macmathuna P

2

1 reference

13 October 2017

Younger K

3

1 reference

13 October 2017

Keeling PW

4

1 reference

13 October 2017

Feely J

5

1 reference

13 October 2017

language of work or name

English

0 references

publication date

1 April 1991

1 reference

British Journal of Clinical Pharmacology

13 October 2017

1 reference

13 October 2017

31

1 reference

13 October 2017

4

1 reference

13 October 2017

488-491

1 reference

Functions of metallothionein

13 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1368340

Hepatic disease and drug pharmacokinetics

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1368340

Genetic control of the phenobarbital-induced shortening of plasma antipyrine half-lives in man.

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1368340

Clinical, endocrinological and biochemical effects of zinc deficiency

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1368340

Commentary: a physiological approach to hepatic drug clearance

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1368340

Histological changes in the liver and indices of drug metabolism in alcoholics

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1368340

Zinc supplementation in alcoholic cirrhosis. A double-blind clinical trial.

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1368340

Factors influencing antipyrine elimination

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1368340

Reduced leucocyte zinc in liver disease

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1368340

Genetic Control of Drug Levels in Man: Antipyrine

18 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1368340

Zinc in plasma, neutrophils, lymphocytes, and erythrocytes as determined by flameless atomic absorption spectrophotometry

18 August 2018

1 reference

12 December 2020

Hepatic zinc content in patients with various stages of alcoholic liver disease and in patients with chronic active and chronic persistent hepatitis

1 reference

12 December 2020

Zinc metabolism in hepatic dysfunction. I. Serum zinc concentrations in Laënnec's cirrhosis and their validation by sequential analysis

1 reference

12 December 2020

Plasma-zinc in health and disease

1 reference

12 December 2020

The influence of magnesium and some other divalent cations on hepatic microsomal drug metabolism in vitro

1 reference

12 December 2020

Hepatic drug metabolism in zinc-deficient rats

1 reference

12 December 2020

Aminopyrine disposition: studies on breath, saliva, and urine of normal subjects and patients with liver disease

1 reference

12 December 2020

Serum zinc and serum copper and indices of drug metabolism in alcoholics

1 reference

12 December 2020

High‐Pressure Liquid Chromatographic Analysis of Antipyrine in Small Plasma Samples

1 reference

12 December 2020

Inhibition of rat hepatic microsomal styrene oxide hydration by mercury and zinc in vitro

1 reference

12 December 2020

Zinc deficiency and photoreceptor dysfunction in chronic liver disease

1 reference

12 December 2020

Oral zinc supplementation improves hepatic encephalopathy. Results of a randomised controlled trial

1 reference

12 December 2020

10.1111/J.1365-2125.1991.TB05568.X

Identifiers

DOI

1 reference

13 October 2017

1 reference

13 October 2017

1 reference